News
-
-
-
COMMUNIQUÉ DE PRESSE
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)
TuHURA and Kintara announce positive results from TuHURA's Phase 1b trial evaluating IFx-2.0 in ICI naïve patients with advanced MCC and cSCC, overcoming resistance to ICI therapy. Data presented at 2024 ASCO Annual Meeting -
-
COMMUNIQUÉ DE PRESSE
Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
Monogram Technologies Inc. to showcase mBôs Precision Robotic Surgical System and mVision Technologies at investor and analyst day on June 20th, 2024 in Austin, TX -
COMMUNIQUÉ DE PRESSE
Elevating Marine Propulsion Reliability - Vision Marine Technologies Files its 5th Patent on its Unique Vehicle Control Unit
Vision Marine Technologies, Inc. announces fifth patent filing for state-of-the-art VCU enhancing electric marine powertrain functionality and innovation in the maritime sector -
COMMUNIQUÉ DE PRESSE
BEWHERE HOLDINGS INC. Announces Plans to Repurchase Common Shares
BeWhere Holdings Inc. announces a Normal Course Issuer Bid to repurchase Common Shares, aiming to acquire 5% of its outstanding shares over the next 12 months. Open market transactions through TSX Venture Exchange -
COMMUNIQUÉ DE PRESSE
Innodata Awarded New Programs from “Magnificent Seven” Big Tech Customer Valued at Approximately $44 Million in Annualized Run Rate Revenue
Innodata Inc. (NASDAQ:INOD) announces new large language model development programs, expecting $44 million annual revenue. Customer commits to multi-year strategy benefiting Innodata -
-
COMMUNIQUÉ RÉGLEMENTÉ
GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres du 27 mai 2024 au 31 mai 2024
Déclaration hebdomadaire des transactions sur actions propres de Guillemot Corporation S.A. du 27 mai 2024 au 31 mai 2024, conformément à la réglementation. Transactions réalisées sur Euronext Paris
